Abortion pill providers remain in limbo on the legality of reproductive care as the Biden administration seeks to stop court-ordered restrictions on mifepristone from going into effect this weekend.
The US Court of Appeals for the Fifth Circuit late Wednesday partially granted the Biden administration’s request for an emergency stay on a Texas federal judge’s mifepristone suspension. The appeals court said the challenge to the 2000 approval of mifepristone appears to be barred by the statute of limitations, but it allowed a stay on changes the FDA has implemented since 2016.
The drug remains available while the appeals process plays ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.